BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOTNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
8.56 USD
↗ 0.25 (3.01%)AT CLOSE (11:59 AM EDT)
8.56
↗ 0.00 (0.00%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
8.56
↗ 0.00 (0.00%)
🟢Market: OPEN

Shares of BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) are trading at $8.17. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. This is driven by negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, BBOT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jul 17, 2026.

Open?$8.26
High?$8.61
Low?$7.94
Prev. Close?$8.31
Volume?269.7K
Avg. Volume?490.8K
VWAP?$8.43
Rel. Volume?0.55x
Bid / Ask
Bid?$7.23 × 100
Ask?$12.43 × 100
Spread?$5.20
Midpoint?$9.83
Valuation & Ratios
Market Cap?665.7M
Shares Out?80.1M
Float?42.4M
Float %?53.0%
P/E Ratio?N/A
P/B Ratio?1.79
EPS?-$1.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
106
Market Cap
665.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.bridgebio.com
Listed
2025-08-12
Address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?12.29%High
Short Interest?5.2M
Days to Cover?7.2
Free Float42.4M
Avg Daily Volume726.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?6.16Strong
Quick Ratio?6.16Strong
Cash Ratio?1.22Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
80
1.79CHEAP▾
P/S?
Peers
100
S&P
3
574,365.86HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
529,549.64HIGH▾
Returns & Efficiency
ROE?
S&P
5
-33.5%WEAK▾
ROA?
S&P
3
-29.9%WEAK▾
Cash Flow & Enterprise
FCF?$-149706358
Enterprise Value?$613.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist